XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 1,621,325 2,763,865 7,514,888 8,991,673
General and administrative 4,447,008 4,808,551 14,626,882 12,755,190
Stock-based compensation – general and administrative 2,719,674 3,061,763 7,946,529 9,198,340
Total Operating Expenses 8,788,007 10,634,179 30,088,299 30,945,203
Operating Loss (8,788,007) (10,634,179) (30,088,299) (30,945,203)
Other Income (Expense)        
Interest income 20,637 204,843 56,658 640,686
Gain on sale of New Jersey net operating losses 2,387,842
Interest expense (172,262) (172,262)
Total Other Income (Expense) (151,625) 204,843 (115,604) 3,028,528
Loss before Income Taxes (8,939,632) (10,429,336) (30,203,903) (27,916,675)
Income tax expense 264,240 144,000 792,720 432,000
Net Loss (9,203,872) (10,573,336) (30,996,623) (28,348,675)
Deemed dividend on warrant extension 321,559 321,559
Net loss attributable to non-controlling interest 414,000 1,522,000
Net loss applicable to common stockholders $ (8,789,872) $ (10,894,895) $ (29,474,623) $ (28,670,234)
Net Loss Per Share - Basic (in Dollars per share) $ (0.8) $ (1.57) $ (3.27) $ (4.37)
Net Loss Per Share - Diluted (in Dollars per share) $ (0.8) $ (1.57) $ (3.27) $ (4.37)
Weighted Average Common Shares Outstanding        
Basic (in Shares) 11,006,896 6,954,278 9,020,356 6,557,892
Diluted (in Shares) 11,006,896 6,954,278 9,020,356 6,557,892